Search

Your search keyword '"Fernández-Rodríguez, Amanda"' showing total 339 results

Search Constraints

Start Over You searched for: Author "Fernández-Rodríguez, Amanda" Remove constraint Author: "Fernández-Rodríguez, Amanda"
339 results on '"Fernández-Rodríguez, Amanda"'

Search Results

5. Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk

7. Dynamics of cellular senescence markers after HCV elimination spontaneously or by DAAs in people living with HIV

9. miRNome profiling of extracellular vesicles in severe COVID-19 patients and identification of predictors of mortality

10. Longer ICU stay and invasive mechanical ventilation accelerate telomere shortening in COVID-19 patients one-year after recovery

11. Altered blood microbiome in patients with HCV-related decompensated cirrhosis.

12. Plasma metabolomic profile is near-normal in people with HIV on long-term suppressive antiretroviral therapy

13. TNFAIP3-interacting protein 1 polymorphisms and their association with symptomatic human respiratory syncytial virus infection and bronchiolitis in infants younger than one year from South Africa: A case-control study

16. Corrigendum to “PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study” [Biomed. Pharmacother. 159 (2023) 114220]

25. HCV spontaneous clearers showed low senescence profile in people living with HIV

26. Dynamics of cellular senescence markers after HCV elimination in people living with HIV

28. Editorial: Precision medicine in viral hepatitis: progress and prospects towards elimination.

29. HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study

30. HCV spontaneous clearers showed low senescence profile in people living with HIV under long ART.

31. Relative telomere length impact on mortality of COVID‐19: Sex differences

34. Different HCV exposure drives specific miRNA profile in PBMCS of HIV patients

35. Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation

36. CEACAM7 polymorphisms predict genetic predisposition to mortality in post-surgical septic shock patients

37. T cell maturation and senescence after HCV cure in HIV-HCV coinfected patients: a prospective study

38. Novel genes and sex differences in COVID-19 severity

39. Relative telomere length impact on mortality of COVID‐19: Sex differences.

40. Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients

41. Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19

42. Plasma miRNA profile at COVID-19 onset predicts severity status and mortality

43. HCV eradication with DAAs differently affects HIV males and females: A whole miRNA sequencing characterization

44. Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis

45. IL-1R1rs6755229 polymorphism is related to death in patients undergoing major surgery who develop septic shock: a retrospective study

47. Are Reduced Levels of Coagulation Proteins Upon Admission Linked to COVID-19 Severity and Mortality?

48. Age-Adjusted Endothelial Activation and Stress Index for Coronavirus Disease 2019 at Admission Is a Reliable Predictor for 28-Day Mortality in Hospitalized Patients With Coronavirus Disease 2019

49. HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients

Catalog

Books, media, physical & digital resources